As we reflect back on our more than 30 years, some of our key accomplishments are:
- Some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
- NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
- Served over 400 clients in four continents on thousands of projects
- Contributed to over 100 IND and IDE submissions
- Organized and lead clients on scores of meetings with regulatory agencies worldwide
- Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
- Served as agent for a multi-million dollar licensing arrangement
- Created several business plans, including one funded at over $80 million
- Had our 225th paper accepted to a peer-reviewed journal
- Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
- Performed 100’s of literature and patent searches, including support for patent arbitration
Dr. Novack chairing breaking news session at ASCPT
